Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1768809

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1768809

Capillary Electrophoresis

PUBLISHED:
PAGES: 153 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Capillary Electrophoresis Market to Reach US$1.5 Billion by 2030

The global market for Capillary Electrophoresis estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Academic Institutes & CROs, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$747.2 Million by the end of the analysis period. Growth in the Pharma & Biotech Companies segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$273.9 Million While China is Forecast to Grow at 9.5% CAGR

The Capillary Electrophoresis market in the U.S. is estimated at US$273.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.3 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Capillary Electrophoresis Market - Key Trends and Drivers Summarized

What Makes Capillary Electrophoresis a Vital Tool in Modern Analytical Chemistry?

Capillary Electrophoresis (CE) is a powerful analytical technique used to separate ionic species based on their size-to-charge ratio, using an electric field applied across a narrow capillary tube filled with an electrolyte solution. The method leverages the principles of electrophoresis, where charged molecules migrate through the capillary at different velocities depending on their charge, size, and the viscosity of the medium. CE is widely utilized for the separation and analysis of biomolecules such as proteins, nucleic acids, and peptides, as well as small molecules like pharmaceuticals and metabolites. The narrow capillary used in CE, typically made of fused silica, allows for efficient heat dissipation even at high voltages, resulting in sharper peaks and improved resolution compared to traditional gel electrophoresis. Furthermore, various modes of CE, such as capillary zone electrophoresis (CZE), micellar electrokinetic chromatography (MEKC), and capillary gel electrophoresis (CGE), allow for a broad range of applications tailored to specific analytical needs. The high separation efficiency, minimal sample volume requirements, and rapid analysis time make CE an ideal tool for both research and clinical settings. It is particularly valuable in the pharmaceutical and biotechnology industries for purity testing, quality control, and the analysis of complex biological samples. As such, capillary electrophoresis has become a cornerstone technique in modern analytical chemistry, providing precise and reproducible results across a variety of disciplines.

What Technological Breakthroughs Are Redefining the Potential of Capillary Electrophoresis?

Technological advancements have significantly expanded the capabilities and applications of capillary electrophoresis, enhancing its sensitivity, automation, and integration with other analytical methods. One of the most impactful developments is the coupling of CE with mass spectrometry (CE-MS), which combines the high-resolution separation power of CE with the mass-based identification capabilities of MS. This hybrid technique allows for detailed structural elucidation of complex biomolecules, such as proteins and oligonucleotides, providing both quantitative and qualitative data in a single analysis. The use of advanced detection systems, such as laser-induced fluorescence (LIF) and UV-vis detectors, has also improved the sensitivity of CE, enabling the detection of low-abundance analytes with high specificity. Automation has been another key area of innovation, with modern CE instruments featuring automated sample handling, capillary rinsing, and data acquisition, reducing the risk of human error and increasing throughput. Additionally, the development of microchip-based CE (MCE) has opened new avenues for miniaturization and high-throughput analysis. These microfluidic platforms, often referred to as "lab-on-a-chip" systems, integrate CE on a small-scale chip, allowing for rapid, parallel analysis with minimal reagent consumption and sample volumes. Another significant advancement is the use of coated capillaries and novel electrolyte formulations that minimize issues such as analyte adsorption and peak broadening, thus enhancing reproducibility and robustness. Furthermore, the emergence of new separation modes, such as chiral CE for the analysis of enantiomers and affinity CE for studying biomolecular interactions, has broadened the scope of CE applications. These technological enhancements have transformed CE into a versatile, high-performance tool for a wide range of scientific fields, from pharmaceutical research to environmental testing.

How Are Changing Research Priorities and Industry Demands Influencing the Capillary Electrophoresis Market?

The capillary electrophoresis market is being shaped by shifting research priorities, growing regulatory demands, and the increasing need for high-resolution, high-throughput analytical techniques in both academia and industry. The expanding scope of proteomics, genomics, and metabolomics research has driven a surge in demand for CE as a tool for the separation and analysis of complex biological samples. Researchers require techniques that offer high sensitivity and specificity, as well as the ability to separate minute sample volumes, making CE a preferred choice for analyzing protein isoforms, DNA fragments, and small metabolites. In the pharmaceutical industry, CE has gained prominence due to its ability to accurately assess drug purity, separate chiral compounds, and profile impurities, which are critical parameters for compliance with stringent regulatory requirements set by agencies like the FDA and EMA. Additionally, the growing emphasis on biopharmaceuticals, such as monoclonal antibodies and gene therapies, has spurred interest in CE for characterizing biologics and ensuring product quality and consistency. Another driving factor is the need for robust, reproducible analytical methods that can be seamlessly integrated into automated workflows, reducing time-to-market and increasing laboratory productivity. The adoption of CE in clinical diagnostics is also rising, particularly for the analysis of hemoglobin variants and detection of genetic disorders, reflecting its expanding role beyond traditional research applications. Furthermore, the trend towards green chemistry and sustainable laboratory practices is boosting the appeal of CE, as it typically requires less organic solvent and generates less waste compared to conventional chromatographic methods. As industry needs evolve towards more precise, rapid, and environmentally friendly analytical solutions, capillary electrophoresis is emerging as a key technology that aligns well with these requirements.

Which Key Factors Are Driving the Rapid Growth of the Capillary Electrophoresis Market?

The growth in the capillary electrophoresis market is driven by several critical factors, including the increasing demand for high-resolution analytical techniques, advancements in CE-MS technology, and the rising need for efficient biomolecule characterization in pharmaceutical and biotechnology sectors. The heightened focus on proteomics, genomics, and personalized medicine has spurred the need for sophisticated analytical tools capable of separating and identifying complex biological mixtures with high accuracy. This has positioned CE as an essential technique for laboratories engaged in cutting-edge research and clinical applications. The integration of CE with mass spectrometry (CE-MS) has been a major growth catalyst, providing enhanced sensitivity and comprehensive molecular profiling capabilities that are invaluable for drug development, biomarker discovery, and forensic analysis. Additionally, regulatory agencies have increasingly endorsed CE for quality control and compliance testing, particularly in the pharmaceutical industry, where it is used to ensure the purity and stability of drug products. The rising prevalence of chronic diseases and the consequent surge in biopharmaceutical research have further fueled the adoption of CE for the analysis of therapeutic proteins, peptides, and nucleic acids. Technological innovations such as microchip-based CE, automated high-throughput systems, and the development of novel separation modes are also expanding the utility of CE across various fields. Another significant driver is the growing emphasis on sustainable laboratory practices, as CE offers a low solvent consumption profile, aligning with green chemistry initiatives aimed at reducing environmental impact. The increasing demand for portable and user-friendly analytical devices in sectors like environmental testing and food safety is also contributing to market growth, as CE-based systems offer compact, reliable solutions for on-site analysis. These diverse growth drivers are transforming the capillary electrophoresis market, positioning it for robust expansion as it continues to meet the evolving needs of scientific research and industry applications.

SCOPE OF STUDY:

The report analyzes the Capillary Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Academic Institutes & CROs, Pharma & Biotech Companies, Other End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Helena Laboratories Corp.
  • Lumex Instruments
  • PerkinElmer Inc.
  • Promega Corp.
  • QIAGEN NV
  • SEBIA SA
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Product Code: MCP17709

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Capillary Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Resolution Separation Techniques Throws the Spotlight on Capillary Electrophoresis
    • Increasing Adoption in Biopharmaceutical Research Propels Market Growth
    • Advancements in Microfluidic Technologies Strengthen the Business Case for Capillary Electrophoresis
    • Expanding Use in Genetic Analysis and DNA Sequencing Generates Demand for CE Systems
    • Growing Emphasis on Analytical Accuracy and Sensitivity Drives Adoption Across Clinical Laboratories
    • Trend Toward Personalized Medicine Expands Addressable Market for Capillary Electrophoresis
    • Here's the Story: Rising Focus on Protein Characterization Sustains Market Growth in Proteomics
    • Innovations in Automated and High-Throughput Systems Propel Interest in CE for Large-Scale Studies
    • Rising Utilization in Food & Beverage Testing Creates New Opportunities in Quality Control
    • Growing Application in Environmental Testing Drives Market Penetration in Non-Traditional Sectors
    • Trend Toward Miniaturization Fuels Adoption of Portable and Field-Deployable CE Systems
    • Emerging Use of CE in Forensic Science Accelerates Adoption for DNA and Biomarker Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Capillary Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Academic Institutes & CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Academic Institutes & CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Academic Institutes & CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Capillary Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Capillary Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Capillary Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Capillary Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!